A large, global life sciences organization identified multiple opportunities to improve their Diversity, Equity, & Inclusion (DEI) strategy within Research & Development (R&D): a lack of centralized DEI ownership, disparate ideas without cohesive management, and a lack of prioritization mechanisms. Furthermore, existing DEI efforts primarily focused on workforce diversity and inclusion, but true advancement required an expanded focus to apply DEI principles to the core business. To achieve this, the team landed on three DEI pillars:
To address these challenges and opportunities, the Vynamic team began with a comprehensive scan of the internal and external environment in efforts to build a long-term DEI roadmap. Elements of this included:
Current state analysis
Across the three pillars (People, Business, Community) Vynamic collected industry best practices of peer organizations, reviewed existing organizational activities through interviews, and conducted a gap analysis.
Inclusive change management
Vynamic designed and executed interactive workshops to solicit additional ideas from a diverse set of voices. This brought out new perspectives and also helped to educate and generate DEI champions across the R&D organization.
Leveraging our DEI and R&D experience, coupled with the internal/external research and stakeholder input, the team developed an actionable R&D DEI Roadmap, outlining key initiatives and investments needed over the next 1-3 years.
The Vynamic team helped bring clarity to disparate DEI initiatives, achieved leadership support, developed an actionable DEI roadmap, and aligned key stakeholders to each priority initiative. The key differentiator Vynamic added to this work was a roadmap that went beyond diversity in hiring and retention, and included DEI principles applied to the “business of life sciences” – including programs focused on equitable access to medicine, diversity of patients and investigators in clinical trials, and building an informed, supporting community-based network of scientists and clinicians. Vynamic and the client mutually believed efforts should reach deeper into the communities we aim to serve and support; that we must push beyond just financial investment and develop sustainable relationships to lift those who have historically lacked access to equitable healthcare and opportunity. This long-term effort will not only help advance client priorities, but also raise the bar for the entire pharma industry and put us in position to lead the charge towards health equity for all.
Vynamic, an Inizio Advisory company, is a leading management consulting partner to global health organizations across Life Sciences, Health Services, and Health Technology. Founded and headquartered in Philadelphia, Vynamic has offices in Boston, Durham NC, and London. Our purpose is simple: We believe there is a better way. We are passionate about shaping the future of health, and for more than 20 years we’ve helped clients transform by connecting strategy to action.
Through a structured, yet flexible delivery model, our accomplished leaders work as an extension of client teams, enabling growth, performance, and culture. Vynamic has been recognized by organizations like Great Place to Work and Business Culture Awards for being leaders and innovators in consulting, company culture, and health. Visit Vynamic.com to discover how we can help transform your
organization or your career.
Vynamic partnered with a top Life Sciences client for a multi-year omnichannel transformation, enhancing customer experience.
In the Medicare Advantage B2C market, learn how Vynamic streamlined touchpoints and cut costs while enhancing satisfaction
A global gene therapy client partnered with Vynamic to optimize its engagement with treatment centers in preparation for a product launch.